Omnicell (OMCL) Long-Term Deferred Tax (2010 - 2026)
Omnicell's (OMCL) quarterly Long-Term Deferred Tax came in at $47.4 million in Q2 2026, down 20.78% year-over-year from $59.8 million in Q2 2025, and down 12.37% quarter-over-quarter from $54.1 million in Q1 2026.
Analysis
Omnicell (OMCL) Long-Term Deferred Tax (2010 - 2026) Analysis & Trends
Omnicell (OMCL) has reported Long-Term Deferred Tax for 17 consecutive years, with $47.4 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Long-Term Deferred Tax fell 20.78% year-over-year to $47.4 million in Q2 2026; TTM through Jun 2026 was $47.4 million, a 20.78% decrease from a year earlier, with the FY2025 full-year figure at $58.3 million, up 1.51% from the prior year.
- Long-Term Deferred Tax was $47.4 million for Q2 2026 at Omnicell, down from $54.1 million in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $61.4 million in Q1 2025 and troughed at $16.1 million in Q1 2022.
- A 5-year average of $39.8 million and a median of $39.0 million in 2024 frame the typical range for Long-Term Deferred Tax.
- Across the five-year window, Long-Term Deferred Tax surged 116.4% in 2023 and slipped 20.78% in 2026, its largest moves.
- Over 5 years, Long-Term Deferred Tax stood at $22.3 million in 2022, then jumped by 47.35% to $32.9 million in 2023, then jumped by 74.67% to $57.5 million in 2024, then advanced by 1.51% to $58.3 million in 2025, then slipped by 18.79% to $47.4 million in 2026.
- The last three Long-Term Deferred Tax figures came in at $47.4 million (Q2 2026), $54.1 million (Q1 2026), and $58.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 47.38 Mn |
| Mar 31, 2026 | 54.06 Mn |
| Dec 31, 2025 | 58.34 Mn |
| Sep 30, 2025 | 56.39 Mn |
| Jun 30, 2025 | 59.81 Mn |
| Mar 31, 2025 | 61.36 Mn |
| Dec 31, 2024 | 57.47 Mn |
| Sep 30, 2024 | 42.09 Mn |
| Jun 30, 2024 | 40.56 Mn |
| Mar 31, 2024 | 37.38 Mn |
| Dec 31, 2023 | 32.90 Mn |
| Sep 30, 2023 | 35.96 Mn |
| Jun 30, 2023 | 32.76 Mn |
| Mar 31, 2023 | 29.56 Mn |
| Dec 31, 2022 | 22.33 Mn |
| Sep 30, 2022 | 16.62 Mn |
| Jun 30, 2022 | 16.13 Mn |
| Mar 31, 2022 | 16.05 Mn |
| Dec 31, 2021 | 15.88 Mn |
| Sep 30, 2021 | 15.87 Mn |